Login
Home / 0101.KL : KLS
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

TMC Life Sciences Berhad

MYR 0.43 -$0.02 (-3.33%)
KLS · 14 Sep 2026 08:50 UTC
Previous Close
MYR 0.43
Day Range
MYR 0.43MYR 0.43
Year Range
MYR 0.41MYR 0.57
Market Cap
757.72M
AVG Volume
102.42K
Trailing/Forward PE
43.5/-
PEG ratio
0.24
Dividend Yield
0.43%
Next Earnings Date
-
Primary Exchange
Malaysian Stock ExchangeMY
Revenue (MYR)
050M100M150M23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
Net Income (MYR)
-5M05M10M23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
Operating Income (MYR)
-5M05M10M15M23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
EBITDA (MYR)
010M20M30M23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
Cash Flows (MYR)
-20M-10M010M20M23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
EPS (MYR)
-0.06-0.04-0.0200.0223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
Expenses (MYR)
010M20M30MSG&ACapex23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
Cash & Debt (MYR)
0100M200M300MCashLong Term DebtShort Term Debt23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
Debt ratios
00.511.5223 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
Margins
0%20%40%60%80%23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
Return on Capital
-0.5%0%0.5%1%1.5%23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
Shares Outstanding
0500M1B1.5B2B23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
Dividends (MYR)
00.010.020.03Feb 18Feb 19Mar 20Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Book Value Per Share (MYR)
00.20.40.623 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
Total Assets (MYR)
0500M1B1.5B23 Q323 Q424 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q4
PE Ratio
0100200300400med 61.76Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Free Cash Flow Yield
-5%-2.5%0%2.5%5%7.5%med 0.41%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price to Sales
1.7522.252.52.753med 2.27Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
EV/EBITDA
7.51012.51517.520med 14.36Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price/Operating Cashflow
10203040med 20.34Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
Price to Book
0.70.80.911.11.2med 0.93Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
TMC Life Sciences Berhad
0101.KL
Stockpicker

Video analysis: 0101.KL

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.